Urology Times staff

Hear insights from experts on key trial data presented at ASCO GU 2025.

Two recent roundtable discussions focused on the challenges and evolving treatment strategies in upper tract urothelial carcinoma.

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

Two case-based roundtable discussions recently covered the advancing of care for patients with low-grade upper tract urothelial carcinoma.

"Over a third of Americans actually use some kind of what we term complementary or alternative medicine approach," says Raevti Bole, MD.

“We really need to do a better job of destigmatizing these conversations so guys are comfortable asking their providers [about sensitive health issues],” says Justin Dubin, MD.

“Now for muscle-invasive [disease], how I counsel patients on surgery when they're a man vs a woman is almost completely different, because their anatomy is very different,” says Ava Saidian, MD.

"We found actually that patients who underpredict their curve during the initial visit, prior to having a formal measurement of their penile curvature, actually ended up having a higher satisfaction following treatment," says Jake Miller, MD.

Michael Jenson, PA-C, gives an overview of the Surgical Impotence Management Strategy program at Minnesota Urology.

"We were actually interested in looking at what was the impact of prostate cancer on sexual quality of life for female partners of patients," says Stacy Loeb, MD, MSc, PhD (hon).

"I think it requires the adequate staff, and then also the development of a practice pattern for how chaperones are used," says Ellen Cahill, MD.

Dhingra discusses the utility of PSMA-PET imaging when treating patients with prostate cancer.

"Most of us are focusing on our healthspan and our lifespan, but we also need to think about our sexspan," says Mohit Khera, MD, MBA, MPH.

"We wanted to study if Dupuytren's contracture has any effect at all in Xiaflex treatment," says Muhammed A. Moukhtar Hammad, MBBCh.

"We had 66 respondents, and 48% of those did say that they had functionally limiting pelvic pain...for 14 days out of a given month at least," says Sarah Ponce.

"I think it's really important when we're prescribing any medication to our patients to really have a good idea of what they can expect," says Evan Panken, MD.

“The other thing that we believe will be important to see is it not only effective where we inject a tumor and turn the light on in the tumor, but will there be abscopal effects throughout the bladder?” says Gary D. Steinberg, MD.

Hehemann gave a talk titled “Burnout/Impostor Syndrome” at the 2024 SMSNA Fall Scientific Meeting in Scottsdale, Arizona.

"There are no formal guidelines on whether chaperone use is recommended or is mandatory," says Ellen Cahill, MD.

“I think one of the biggest challenges women have in general in terms of diagnosis of bladder cancer is that it tends to be delayed,” says Ava Saidian, MD.

“Over 80% of the patients are greater than 50% improved, and 50% [had] over [a] 75% reduction in UUI episodes,” says Cindy L. Amundsen, MD.

"If you are going to be an inclusive leader...it's important that you think about those gaps in education and hopefully try to fill those," says Denise Asafu-Adjei, MD, MPH.

"I think that using this database does allow for some generalizability, and we're pretty confident in that," says Evan Panken, MD.

Raevti Bole, MD, recently presented a talk at the SMSNA Fall Scientific Meeting on nonsurgical BPH management.

"The communication piece is everything," says Amy Pearlman, MD.

"The biggest complaint we saw, as far as negative outcomes, was loss of length," says Landon Trost, MD.

Bridget Koontz, MD, highlights the design and enrollment criteria of the ongoing phase 2 NRG-GU011 trial.

“The preliminary findings were quite favorable in that we saw, especially in the low-grade population, complete elimination of tumor cells on the biopsies, on the transurethral resection of bladder tumors,” says Gary D. Steinberg, MD.